Cure My Disease

Don't miss your cure!

 Log in / Sign up

Electric baths may ease diabetic nerve pain and improve balance

NCT ID NCT07590011

Symptom relief Sponsor: Ankara Etlik City Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether adding a four-cell galvanic bath therapy to standard rehabilitation could reduce pain and improve balance in people with diabetic nerve damage. 66 adults with type 2 diabetes and diabetic neuropathy participated. Over 4 weeks, some received the bath therapy plus rehab, while others had rehab alone. The results will show if this bath therapy is a helpful supportive treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

66 people

The number who actually took part.

Started

Dec 2024

Finished

Mar 2026

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

40 to 75 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Diagnosis of type 2 diabetes mellitus 2. Confirmed diagnosis of diabetic distal symmetric polyneuropathy according to the 2009 Toronto Consensus criteria 3. Age between 40 and 75 years 4. Adequate cognitive function to understand and respond to questionnaires and follow instructions (Mini-Mental State Examination score ≥ 24) 5. No initiation or dosage change in neuropathic pain medication within the last 1 month 6. Sufficient functional mobility to participate in the assessment and treatment protocol (ability to stand independently or with minimal assistance) Exclusion Criteria: 1. Presence of lower extremity amputation 2. Active diabetic foot ulcer, significant skin integrity impairment, or open wound in the treatment area 3. Cognitive impairment (MMSE \< 24) or communication problems interfering with assessments 4. Presence of orthopedic, musculoskeletal, or peripheral conditions affecting balance 5. Medical instability 6. Use of medications affecting balance or cognitive function 7. Use of assistive devices 8. Severe musculoskeletal disorders 9. Initiation or dosage change of neuropathic pain medication within the last 1 month 10. Presence of Charcot neuroarthropathy 11. Polyneuropathy due to causes other than diabetes

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Diabetic distal symmetric polyneuropathy are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

diabetic polyneuropathy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Diabetic distal symmetric polyneuropathy

Contacts and locations

Locations

  • Ankara Etlik City Hospital Physical Medicine and Rehabilitation Hospital

    Ankara, Turkey (Türkiye)